These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7563525)

  • 21. Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis.
    Holm EA; Randløv A; Strandgaard S
    Blood Press; 1996 Nov; 5(6):360-2. PubMed ID: 8973754
    [No Abstract]   [Full Text] [Related]  

  • 22. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL; Porter JA
    Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan in heart failure: preclinical experiences and initial clinical outcomes.
    Sweet CS; Rucinska EJ
    Eur Heart J; 1994 Dec; 15 Suppl D():139-44. PubMed ID: 7713103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Walser M
    N Engl J Med; 2002 Feb; 346(9):705-7. PubMed ID: 11873778
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible acute renal failure induced by losartan in a renal transplant recipient.
    Ostermann M; Goldsmith DJ; Doyle T; Kingswood JC; Sharpstone P
    Postgrad Med J; 1997 Feb; 73(856):105-7. PubMed ID: 9122087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angiotensin II receptor antagonists. Clinical relevance].
    Scholze J
    Internist (Berl); 1996 Jun; 37(6):636-42. PubMed ID: 8767999
    [No Abstract]   [Full Text] [Related]  

  • 29. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM; Goldberg AI
    Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI; Dunlay MC; Sweet CS
    Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin II receptor antagonists].
    Bornkessel B
    Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710
    [No Abstract]   [Full Text] [Related]  

  • 34. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
    Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
    J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report.
    Weber MA
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):247S-251S. PubMed ID: 1290620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug reduction in the elderly.
    Freeman JW
    S D J Med; 1996 Dec; 49(12):439. PubMed ID: 8997149
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute oliguric renal failure associated with angiotensin II receptor antagonists.
    Lee HY; Kim CH
    Am J Med; 2001 Aug; 111(2):162-3. PubMed ID: 11501548
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension.
    Ogihara T; Yoshinaga K
    Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin receptor antagonists as a treatment for hypertension.
    MacFadyen RJ; Reid JL
    J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.